Exchange: NASDAQ·Updated 07:58 PM EDT
VRAX logo

VRAX Virax Biolabs Group Ltd

$1.87
$0.12
(6.03%)
Today
Closed $1.87
$0.03
(1.60%)
After Hours
Mkt Cap$2.68M
Vol88,540.00

About VRAX

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
83

Extremely Bullish Sentiment

How do you feel about VRAX?

Community Summary

Discussion centers on VRAXs sharp, volatile low-float swings, with bulls citing potential short squeezes, virus-related speculation and the Fosun deal while skeptics warn of pump-and-dump action, dilution and weak fundamentals.

Last updated: 12h agoAI generated, may contain errors

SDBiotechInvestor
$VRAX Wouldn't be surprised to see them announce another contract (even government) in near term.
1
SDBiotechInvestor
$VRAX If Russia plague fears deepen things could get interesting here. Trump to talk with Putin soon.
1
DipBuyPro
If you like to find the runners early - Join the group of bulls below One of the best FREE small cap communities i know of 🔥 🫡💯 $VRAX $OTLK $EONR On everyones radar too
ciccarj
$VRAX sold my 30k shares above 3. I know this stock is heavily shorted debating if I should buy back?
YouVSYou
Reclaim 2.40 and hold the retest / watch 2.63–2.65 then 2.90–3.01 / lose 2.26 and watch 2.14 then 2.02 $VRAX
TraderBuckNKY
$VRAX ...Just out:...Prospectus Rule 434B3... of up to 1,682,360 ordinary shares, par value $0.025 per share (the “Ordinary Shares”), issuable upon exercise of (i) warrants to purchase up to 1,644,000 Ordinary Shares, consisting of Series A Ordinary Share Preferred Investment Options to purchase up to an aggregate of 548,000 Ordinary Shares (the “Series A Preferred Investment Options”) and Series B Ordinary Share Preferred Investment Options to purchase up to an aggregate of 1,096,000 Ordinary Shares (the “Series B Preferred Investment Options,” and together with the Series A Preferred Investment Options, the “New Warrants”), which were issued by us pursuant to an inducement letter agreement dated July 9, 2026 .The exercise price of the New Warrants is $ 6.00 per share. See “Use of Proceeds”. The exercise price of the Placement Agent Warrants is $7.50 per share.

Advertisement|Remove ads.